Novel Uses for Oral Solid Doses Driving Lifecycle Management Strategies
PATHEON SPONSORED CONTENT

Novel Uses for Oral Solid Doses Driving Lifecycle Management Strategies

With few potentially epic drugs in the pharma pipeline right now, drug companies are seeking options to meet the needs of patients and increase revenue in the oral solid dosage (OSD) arena. Current strategies include exploring fixed dose combinations, reformatted injectables, and drugs that carry digital, ingestible sensors that can send information directly to a physician. Currently there is only one. Portfolio expansion implementing lifecycle management strategies is less expensive than developing a new drug from scratch, as safety and efficacy have been previously established. In this white paper, Thermo Fisher Scientific shares ideas and opportunities that brand managers looking to expand their portfolios in a cost-effective manner - while helping patients - will find helpful.

Download the Document

    * denotes a required field

    Please fill out the information below. If you are already registered, and this information will be filled out for you.

  • Please enter your first and last name.

  • Please enter the name of the company or institution you work at.

  • Please enter your mailing address.

  • Please enter the e-mail address you would like to be contacted at.

  • Please enter the phone number you would like to be contacted at.

    • By submitting this form, you consent to American Pharmaceutical Review storing your email address and contact information and transmitting your contact information to the content sponsor. You may request to be removed at any time.